Lab Test | Patient Value | Normal Value |
---|---|---|
CRP | < 0.5 mg/dL | < 1.0 mg/dL |
ESR | 9 mm/hr | 0–20 mm/hr |
Complements (C3, C4) | C3: 12 mg/dL C4: 2 mg/dL | C3: 65–180 mg/dL C4: 13–52 mg/dL |
beta 2-glycoprotein IgA QN | 7.0 Units/mL | 0.0–6.9 Units/mL |
beta-2 glycoprotein IgG QN | 5.8 Units/mL | 0.0–6.9 Units/mL |
beta-2 glycoprotein IgM QN | 1.1 Units/mL | 0.0–6.9 Units/mL |
anti-cardiolipin antibody IgA | 5.9 APL Units | > 22 APL Units may be clinically significant |
anti-cardiolipin antibody IgG | 6.5 GPL Units | 0.0–9.9 GPL Units |
anti-cardiolipin antibody IgM | 4.8 MPL Units | 0.0–9.9 MPL Units |
lupus anticoagulant | 31.6 s | 24.3–42.6 s |
ANA | < 1:40 | < 1:80 |
Anti-dsDNA (on presentation) | 82.2 IU/mL | 0.0–9.9 IU/mL |
Anti-dsDNA (13 months after treatment) | 8.6 IU/mL | 0.0–9.9 IU/mL |
Anti-Smith | > 8.0 | > 1.0 Test Value Positive |
Anti-SSA EIA | > 8.0 | > 1.0 Test Value Positive |
Anti-SSB EIA | 1.2 | > 1.0 Test Value Positive |
Anti-RNP | 2.1 | > 1.0 Test Value Positive |
Anti-Smith/RNP EIA | 5.7 | > 1.0 Test Value Positive |
Anti-Ribosomal P EIA | > 8.0 | > 1.0 Test Value Positive |
Anti-Neuronal serum Ab | > 400 Units | 0–54 Units |